Data / Form D filings / Gila Therapeutics, Inc.
Gila Therapeutics, Inc.: Form D filings
Gila Therapeutics, Inc., a biotechnology company in Edina, MN, filed 8 Form D notices with the SEC between 2016 and 2023. The latest, on December 6, 2023, reports $399,572 sold of a $10 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5420 Highwood Drive West, Edina, MN, 55436
- Phone
- (612) 805-9054
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1673503
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 6, 2023 | New notice | $10,000,000 | $399,572 | $9,600,428 | 7 | Nov 22, 2023 | sec.gov |
| Nov 29, 2022 | New notice | $5,000,000 | $355,522 | $4,644,478 | 6 | Nov 15, 2022 | sec.gov |
| Nov 12, 2021 | Amendment | $1,250,000 | $1,250,000 | 28 | Jan 29, 2021 | sec.gov | |
| Feb 16, 2021 | New notice | $500,000 | $401,934 | $98,066 | 17 | Jan 29, 2021 | sec.gov |
| Mar 13, 2019 | New notice | $2,000,000 | $314,434 | $1,685,566 | 3 | Mar 4, 2019 | sec.gov |
| Apr 18, 2017 | Amendment | $4,000,000 | $3,344,885 | $655,115 | 33 | Apr 15, 2016 | sec.gov |
| Feb 13, 2017 | New notice | $500,000 | $0 | $500,000 | 0 | Yet to occur | sec.gov |
| May 2, 2016 | New notice | $3,200,000 | $2,584,724 | $615,276 | 25 | Apr 15, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Timothy Barberich | Director | |
| Christopher De Souza | Director | |
| Praveen Tyle | Director | |
| Jon Freeman | Executive Officer | |
| Thomas Vasicek | Executive Officer | |
| Richard Horan | Director | |
| Scott Schorer | Executive Officer, Director | |
| Sangeeta Kashyap | Executive Officer |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Dec 4, 2023 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Gila Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.